Donate

Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

PATH is advancing health equity around the world

April 2, 2025
Uganda launches Africa’s largest malaria vaccine rollout to date
March 25, 2025
Fewer shots, more protection: The promise of combination vaccines
March 20, 2025
How local heroes are reshaping disability care in Mozambique

Stay informed

Featured Press Coverage

April 18, 2024
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
May 5, 2025
Ensuring oxygen access is essential to achieving health for all
Devex
February 12, 2024
Could new vaccines end malaria in Africa?
Al Jazeera

Recent Press Coverage

  1. How can the G20 build stronger digital health systems?
    From health data exchanges to a telemedicine task force, PATH’s Varun Kaul and co-author Anirban Sarma break down eight approaches that the G20 could take to strengthen digital health across its member states.
    Published: October 2023
  2. A new vaccine will change the balance of the fight against meningitis
    The novel meningococcal conjugate vaccine, Men5CV, developed by the Serum Institute of India and PATH, is expected to be more affordable and accessible to meningitis belt countries.
    Published: October 2023
  3. Africa’s Current and Planned Vaccine Manufacturing Capacity
    The Africa Centres for Disease Control and Prevention, the Clinton Health Access Initiative, and PATH examined the current and planned vaccine manufacturing capacity in Africa.
    Published: October 2023
  4. African vaccine manufacturing capacity
    The Africa Centres for Disease Control and Prevention (Africa CDC), the Clinton Health Access Initiative, and PATH have released a new briefing paper, Current and Planned Vaccine Manufacturing in Africa, which assesses vaccine manufacturing capacity.
    Published: October 2023
Previous
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

964 Item s
964 Item s
    Date
    From
    To
  1. Join PATH at the African MedTech Conference 2025
    From August 27-29, 2025, PATH will join colleagues from Africa's medical technology community for the African MedTech Conference (TAMC 2025).
    Published: August 2025
    Announcement
  2. Unitaid announces two new flagship investments to boost regional manufacturing of diagnostics and medicines in Africa
    Unitaid is making a foundational investment of nearly US$ 50 million in two flagship programs aimed at strengthening the ability of countries in Africa to produce their own medical tests and treatments.
    Published: August 2025
    Announcement
  3. New study examines how generative AI can assist community health workers in Rwanda
    PATH and partners are conducting a research trial to assess how an AI knowledge assistant can help community health workers better triage and treat their patients.
    Published: July 2025
    Press Release
  4. PATH awarded Bristol Myers Squibb Foundation grant to tackle hemoglobinopathies in India
    New initiative aims to build capacity in high-prevalence areas to increase screening and prevention of inherited blood disorders.
    Published: July 2025
    Announcement
  5. World Hepatitis Day: The partnership advancing hepatitis B care and prevention for mothers and newborns
    On World Hepatitis Day, a new initiative implemented by PATH and backed by Gavi, the Vaccine Alliance and Unitaid is taking aim at an urgent but overlooked threat to newborn health: hepatitis B.
    Published: July 2025
    Press Release
Next